BioSig Technologies (NASDAQ:BSGM) Stock Price Up 7.2%

BioSig Technologies Inc (NASDAQ:BSGM) shares rose 7.2% during mid-day trading on Wednesday . The stock traded as high as $6.88 and last traded at $6.83. Approximately 148,123 shares were traded during trading, an increase of 16% from the average daily volume of 127,798 shares. The stock had previously closed at $6.37.

BSGM has been the topic of several research reports. Laidlaw set a $11.00 price objective on BioSig Technologies and gave the stock a “buy” rating in a report on Wednesday, February 20th. Zacks Investment Research downgraded BioSig Technologies from a “hold” rating to a “sell” rating in a report on Tuesday, April 16th.

The company has a quick ratio of 10.99, a current ratio of 10.99 and a debt-to-equity ratio of 0.02.

BioSig Technologies (NASDAQ:BSGM) last posted its quarterly earnings data on Monday, April 15th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.03). As a group, research analysts predict that BioSig Technologies Inc will post -1.17 EPS for the current year.

In other BioSig Technologies news, CEO Kenneth L. Londoner bought 6,000 shares of the company’s stock in a transaction on Thursday, May 23rd. The stock was bought at an average price of $6.88 per share, for a total transaction of $41,280.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Kenneth L. Londoner bought 15,000 shares of the company’s stock in a transaction on Monday, May 20th. The shares were acquired at an average price of $7.78 per share, with a total value of $116,700.00. The disclosure for this purchase can be found here. In the last ninety days, insiders have acquired 40,150 shares of company stock worth $289,165. Company insiders own 26.70% of the company’s stock.

Institutional investors have recently modified their holdings of the business. Deutsche Bank AG bought a new stake in shares of BioSig Technologies during the 4th quarter valued at $58,000. Morgan Stanley raised its position in shares of BioSig Technologies by 212.1% during the 1st quarter. Morgan Stanley now owns 11,547 shares of the company’s stock valued at $71,000 after acquiring an additional 7,847 shares during the last quarter. Northern Trust Corp bought a new stake in shares of BioSig Technologies during the 1st quarter valued at $80,000. BlackRock Inc. bought a new stake in shares of BioSig Technologies during the 1st quarter valued at $365,000. Finally, Cornerstone Wealth Group LLC bought a new stake in shares of BioSig Technologies during the 1st quarter valued at $368,000. Institutional investors own 4.87% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “BioSig Technologies (NASDAQ:BSGM) Stock Price Up 7.2%” was reported by WKRB News and is the sole property of of WKRB News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.wkrb13.com/2019/06/13/biosig-technologies-nasdaqbsgm-stock-price-up-7-2.html.

About BioSig Technologies (NASDAQ:BSGM)

BioSig Technologies, Inc, a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures.

Featured Article: What is a blue-chip stock?

Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.